Cargando…

Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models

SIMPLE SUMMARY: Although immune checkpoint inhibitors have a potential role in thyroid-related complications, no study has investigated factors associated with such adverse events. This study aims to explore the factors associated with thyroid-related adverse events in patients with anti-PD-1/PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Woorim, Cho, Young-Ah, Kim, Dong-Chul, Jo, A-Ra, Min, Kyung-Hyun, Lee, Kyung-Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582564/
https://www.ncbi.nlm.nih.gov/pubmed/34771631
http://dx.doi.org/10.3390/cancers13215465
_version_ 1784597016502861824
author Kim, Woorim
Cho, Young-Ah
Kim, Dong-Chul
Jo, A-Ra
Min, Kyung-Hyun
Lee, Kyung-Eun
author_facet Kim, Woorim
Cho, Young-Ah
Kim, Dong-Chul
Jo, A-Ra
Min, Kyung-Hyun
Lee, Kyung-Eun
author_sort Kim, Woorim
collection PubMed
description SIMPLE SUMMARY: Although immune checkpoint inhibitors have a potential role in thyroid-related complications, no study has investigated factors associated with such adverse events. This study aims to explore the factors associated with thyroid-related adverse events in patients with anti-PD-1/PD-L1 agents by training predictive models utilizing various machine learning approaches. The results of this study could be used to develop individually tailored intervention strategies to prevent immune checkpoint inhibitor-induced thyroid-related outcomes. ABSTRACT: Targets of immune checkpoint inhibitors (ICIs) regulate immune homeostasis and prevent autoimmunity by downregulating immune responses and by inhibiting T cell activation. Although ICIs are widely used in immunotherapy because of their good clinical efficacy, they can also induce autoimmune-related adverse events. Thyroid-related adverse events are frequently associated with anti-programmed cell death 1 (PD-1) or anti-programmed cell death-ligand 1 (PD-L1) agents. The present study aims to investigate the factors associated with thyroid dysfunction in patients receiving PD-1 or PD-L1 inhibitors and to develop various machine learning approaches to predict complications. A total of 187 patients were enrolled in this study. Logistic regression analysis was conducted to investigate the association between such factors and adverse events. Various machine learning methods were used to predict thyroid-related complications. After adjusting for covariates, we found that smoking history and hypertension increase the risk of thyroid dysfunction by approximately 3.7 and 4.1 times, respectively (95% confidence intervals (CIs) 1.338–10.496 and 1.478–11.332, p = 0.012 and 0.007). In contrast, patients taking opioids showed an approximately 4.0-fold lower risk of thyroid-related complications than those not taking them (95% CI 1.464–11.111, p = 0.007). Among the machine learning models, random forest showed the best prediction, with an area under the receiver operating characteristic of 0.770 (95% CI 0.648–0.883) and an area under the precision-recall of 0.510 (95%CI 0.357–0.666). Hence, this study utilized various machine learning models for prediction and showed that factors such as smoking history, hypertension, and opioids are associated with thyroid-related adverse events in cancer patients receiving PD-1/PD-L1 inhibitors.
format Online
Article
Text
id pubmed-8582564
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85825642021-11-12 Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models Kim, Woorim Cho, Young-Ah Kim, Dong-Chul Jo, A-Ra Min, Kyung-Hyun Lee, Kyung-Eun Cancers (Basel) Article SIMPLE SUMMARY: Although immune checkpoint inhibitors have a potential role in thyroid-related complications, no study has investigated factors associated with such adverse events. This study aims to explore the factors associated with thyroid-related adverse events in patients with anti-PD-1/PD-L1 agents by training predictive models utilizing various machine learning approaches. The results of this study could be used to develop individually tailored intervention strategies to prevent immune checkpoint inhibitor-induced thyroid-related outcomes. ABSTRACT: Targets of immune checkpoint inhibitors (ICIs) regulate immune homeostasis and prevent autoimmunity by downregulating immune responses and by inhibiting T cell activation. Although ICIs are widely used in immunotherapy because of their good clinical efficacy, they can also induce autoimmune-related adverse events. Thyroid-related adverse events are frequently associated with anti-programmed cell death 1 (PD-1) or anti-programmed cell death-ligand 1 (PD-L1) agents. The present study aims to investigate the factors associated with thyroid dysfunction in patients receiving PD-1 or PD-L1 inhibitors and to develop various machine learning approaches to predict complications. A total of 187 patients were enrolled in this study. Logistic regression analysis was conducted to investigate the association between such factors and adverse events. Various machine learning methods were used to predict thyroid-related complications. After adjusting for covariates, we found that smoking history and hypertension increase the risk of thyroid dysfunction by approximately 3.7 and 4.1 times, respectively (95% confidence intervals (CIs) 1.338–10.496 and 1.478–11.332, p = 0.012 and 0.007). In contrast, patients taking opioids showed an approximately 4.0-fold lower risk of thyroid-related complications than those not taking them (95% CI 1.464–11.111, p = 0.007). Among the machine learning models, random forest showed the best prediction, with an area under the receiver operating characteristic of 0.770 (95% CI 0.648–0.883) and an area under the precision-recall of 0.510 (95%CI 0.357–0.666). Hence, this study utilized various machine learning models for prediction and showed that factors such as smoking history, hypertension, and opioids are associated with thyroid-related adverse events in cancer patients receiving PD-1/PD-L1 inhibitors. MDPI 2021-10-30 /pmc/articles/PMC8582564/ /pubmed/34771631 http://dx.doi.org/10.3390/cancers13215465 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Woorim
Cho, Young-Ah
Kim, Dong-Chul
Jo, A-Ra
Min, Kyung-Hyun
Lee, Kyung-Eun
Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_full Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_fullStr Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_full_unstemmed Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_short Factors Associated with Thyroid-Related Adverse Events in Patients Receiving PD-1 or PD-L1 Inhibitors Using Machine Learning Models
title_sort factors associated with thyroid-related adverse events in patients receiving pd-1 or pd-l1 inhibitors using machine learning models
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582564/
https://www.ncbi.nlm.nih.gov/pubmed/34771631
http://dx.doi.org/10.3390/cancers13215465
work_keys_str_mv AT kimwoorim factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT choyoungah factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT kimdongchul factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT joara factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT minkyunghyun factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels
AT leekyungeun factorsassociatedwiththyroidrelatedadverseeventsinpatientsreceivingpd1orpdl1inhibitorsusingmachinelearningmodels